Induction of a protective immune response by mucosal vaccination with a DISC HSV-1 vaccine

Vaccine

Volumn 14, Issue 10, 1996, Pages 987-992

  McLean, C S ^a   Ni Challanain D ^b   Duncan, I ^a   Boursnell, M E G ^a   Jennings, R ^b   Inglis, S C ^a  

^a Cantab Pharmaceuticals Ltd   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

DISC HSV 1 vaccine; Guinea pig model of HSV infection; Local antibody levels; Mucosal immunization

Indexed keywords

HERPES SIMPLEX VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INACTIVATED VIRUS VACCINE; LIVE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENITAL HERPES; GUINEA PIG; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; INTRANASAL DRUG ADMINISTRATION; MUCOSA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VACCINATION; VAGINA SMEAR; VERO CELL; VIRUS REPLICATION; VIRUS TITRATION;

EID: 0030198327     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00259-4     Document Type: Article

References (17)

1. 1 Farrell, H., McLean, C.S., Harley, C., Efsatathiou, S., Inglis, S.C. and Minson, A.C. Vaccine potential of a herpes simplex type 1 mutant with an essential glycoprotein deleted. J. Virol. 1994, 68, 927-932
2. 2 McLean, C.S., Erturk, M., Jennings, R. et al. Protective vaccination against primary and recurrent disease caused by herpes simplex virus (HSV) type-2 using a genetically disabled HSV-1. J. Infect. Dis. 1994, 170, 1100-1109
3. 3 Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N. and Minson, A.C. Construction and properties of a mutant herpes simplex virus type 1 with glycoprotein gH sequences deleted. J. Virol. 1992, 66, 341-348
4. 4 McGhee, J.R., Mestecky, J., Dertzbaugh, M.T., Eldridge, J.H., Hirasawa, M. and Kiyono, H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 1992, 10, 75-88
5. 5 Mestecky, J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 1987, 7, 265
6. 6 Erturk, M., Phillpotts, R.J., Welch, M.J. and Jennings, R. Efficacy of HSV-ISCOM vaccine in the guinea-pig model of HSV-2 infection. Vaccine 1991, 9, 728-734
7. 7 Ogra, P.L., Leibovitz, E.E. and Zhao-Ri, G. Oral immunisation and secretory immunity to viruses. Curr. Top. Immunol. 1989, 146, 73
8. 8 McDermott, M.R., Brais, L.J. and Eveleigh, M.J. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 1990, 71, 1497-1504
9. 9 McDermott, M.R., Goldsmith, C.H., Rosenthal, K.L. and Brais, L.J. T lymphocytes in genital lymphnodes protect mice from intravaginal infection with herpes simplex virus type 2. J. Infect. Dis. 1989, 159, 460-166
10. 10 Irie, H., Harada, Y. and Kataoka, M. et al. Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine. J. Virol. 1992, 66, 2428-2434
11. 11 Irie, H., Shimeld, C., Williams, N. and Hill, T. Protection against ocular and cutaneous infection with herpes simplex virus type 1 by intragastric immunisation with live virus. J. Gen. Virol. 1993, 74, 1357-1362
12. 12 Rooney, J.F., Wohlenberg, C., Cremer, K.J. and Notkins, A.L. Immunised mice challenged with herpes simplex virus by the intranasal route show protection against latent infection. J. Infect. Dis. 1989, 159, 974-976
13. 13 Gallichan, W.S., Johnson, D.C., Graham, F.L. and Rosenthal, K.L. Mucosal immunity and protection after intranasal immunisation with recombinant adenovirus expressing herpes simplex virus glycoprotein. Br. J. Infect. Dis. 1993, 168, 622-629
14. 14 Murphy, B.R., Chanock, R.M. Fields, B.N., and Knipe, B.T. Virology, 1990, 469-502. Raven Press, New York
15. 15 Bowen, J.C., Alphar, H.O., Phillpotts, R. and Brown, M.R.W. Mucosal delivery of herpes simplex virus vaccine. Res. Virol. 1992, 143, 269-278
16. 16 McBride, B.W., Ridgeway, P., Phillpotts, R. and Newell, D.G. Mucosal antibody response to vaginal infection with herpes simplex virus in prevaccinated guinea-pigs. Vaccine 1988, 6, 414-118
17. 17 Ashley, R., Wald, A. and Corey, L. Cervical antibodies in patients with oral herpes simplex virus type 1 (HSV-1) infection: local anamnestic responses after genital HSV-2 infection. J. Virol. 1994, 68, 5284-5286